The Control and Prevention of COVID-19 Transmission in Children: A Protocol for Systematic Review and Meta-analysis

Gidyenne Christine Bandeira Silva de Medeiros1, Ana Clara de França Nunes1, Kesley Pablo Morais de Azevedo1

  • 1Department of Public Health, Postgraduate Program in Public Health, Federal University of Rio Grande do Norte, Natal/RN, Brazil.

Medicine
|August 7, 2020
PubMed

Insights

This systematic review synthesizes evidence on COVID-19 in children and adolescents, focusing on transmission, clinical features, and prevention strategies. It aims to inform new control measures for the pediatric population.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • The COVID-19 pandemic caused by SARS-CoV-2 has had a global impact, with limited data on pediatric populations.
  • Understanding COVID-19 in children and adolescents is crucial for effective public health strategies.

Purpose of the Study:

  • To systematically review evidence on the control and prevention of COVID-19 transmission in children and adolescents.
  • To describe the epidemiological, clinical, and immunological characteristics of COVID-19 in pediatric populations.
  • To identify the role of children and adolescents in SARS-CoV-2 transmission dynamics.

Main Methods:

  • Systematic review protocol developed following PRISMA-P guidelines.
  • Searches conducted across major databases (PubMed, Web of Science, Scopus, etc.) for relevant studies.
  • Inclusion of clinical trials, observational studies, and case reports involving SARS-CoV-2 infected children and adolescents (≤19 years).
  • Risk of bias assessment using established tools (Cochrane's RoB 2.0, ROBINS-I, CASP).
  • Data synthesis through meta-analysis, subgroup, or descriptive analyses as appropriate.

Main Results:

  • A comprehensive synthesis of evidence on the epidemiological profile of COVID-19 in children and adolescents.
  • Detailed description of clinical and immunological characteristics associated with pediatric COVID-19 cases.
  • Insights into the participation of pediatric populations in SARS-CoV-2 transmission dynamics.

Conclusions:

  • This systematic review provides critical evidence for understanding COVID-19 in children and adolescents.
  • Findings will support the development of targeted control and prevention strategies for the pediatric population.
  • The study highlights the importance of continued research into pediatric infectious diseases.
Abstract

Related Concept Videos

Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
111
Controls in Experiments01:13

Controls in Experiments

When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
14.6K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
153
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.7K